4D Lifetec has the vision to create a breakthrough in early cancer diagnostics

4D Lifetec has developed a revolutionary, non-genomic, liquid biopsy assay for multiple cancer types at the earliest possible stage. Its 4D Lifetest™ assay, backed by clinical data and several IVD-CE marks, has the potential to detect the most relevant types of cancer from a blood sample. Our novel and proprietary transformational biomarker DDS has demonstrated high sensitivity remarkably earlier than genomic assays. It is therefore one of the first tests to fulfill a central promise of cancer liquid biopsy.

4D Lifetest™ Lung Dx

4D Lifetest™ Lung Dx is our flagship product and the first non-invasive CE IVD certified blood liquid biopsy assay to assess lung cancer formation at its earliest stage. This diagnostic information is a breakthrough progress to tackle the catastrophic mortality rates of lung cancer patients and protect benign patients from the invasive stress of frequently repeated surveillance diagnostics.